The sales for the September 2024 quarter moved up 42.31% to Rs. 3700.00 millions as compared to Rs. 2600.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2024 is Rs. -360.00 millions as compared to Net Loss of Rs. -1070.00 millions of corresponding quarter ended September 2023 Operating profit Margin for the quarter ended September 2024 improved to 600.00% as compared to -40.00% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 3700.00 2600.00 42.31 7220.00 5110.00 41.29 11540.00 10720.00 7.65
Other Income 110.00 60.00 83.33 380.00 120.00 216.67 410.00 670.00 -38.81
PBIDT 600.00 -40.00 -1600.00 1670.00 -30.00 -5666.67 50.00 1370.00 -96.35
Interest 530.00 590.00 -10.17 1110.00 1170.00 -5.13 2370.00 2290.00 3.49
PBDT 70.00 -630.00 -111.11 560.00 -1340.00 -141.79 -2460.00 -3270.00 -24.77
Depreciation 430.00 440.00 -2.27 860.00 880.00 -2.27 1760.00 1860.00 -5.38
PBT -360.00 -1070.00 -66.36 -300.00 -2220.00 -86.49 -4220.00 -5130.00 -17.74
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -470.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -470.00 0.00
PAT -360.00 -1070.00 -66.36 -300.00 -2220.00 -86.49 -4220.00 -4660.00 -9.44
Equity 770.00 720.00 6.94 770.00 720.00 6.94 770.00 720.00 6.94
PBIDTM(%) 16.22 -1.54 -1154.03 23.13 -0.59 -4039.74 0.43 12.78 -96.61

Wockhardt Share Price

1345.90 -17.25 (-1.27%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×